DNA Repair and Tobacco Smoke in Bladder Carcinogenesis

DNA 修复和烟草烟雾在膀胱癌发生中的作用

基本信息

项目摘要

Bladder cancer (BC) is the fifth most frequent cancer found in the United States (US). Tobacco smoke (TS) is the major cause of BC in US, and tobacco smokers have a 5-fold higher BC incidence than nonsmokers. TS contains more than 60 carcinogens; however, which carcinogens are responsible for BC is not well established. Arylamines, 4-hydroxy-aminoblphenyl (ABP) in particular, are the major cause of occupation-related BC, but the amount of arylamines in TS is minute. In fact, TS contains 100,000 fold more acrolein (Acr) than ABP, and Acr is a potent and organ-specific carcinogen capable of Inducing BC in rat models. Our laboratory has a longstanding interest in studying the role of chemical carcinogen induced DNA damage and repair in tumorigenesis. We recently made three important findings regarding Acr: (1) Acr damages DNA by forming Acr-DNA adducts that are mutagenic; (ii) Acr inhibits DNA repair by modifying and accelerating autophagy-mediated degradation of the modified DNA repair proteins; and (iii) Acr-DNA adducts are poorly repaired in human cells. We propose that Acr Is a major bladder carcinogen and its carcinogenicity Is via these three detrimental effects (Hypothesis 1). Most BC can be classified as either noninvasive (N-lnv) or invasive (Inv); while N-lnv-BC often bear mutations in codon 12 ofthe H-RAS (<20%) and codons 248, 249, 372 and 652 ofthe FGFRS gene (80%), Inv-BC mainly carry mutations in the p53 (30-60%) and RB genes. We hypothesize that these mutation hotspots in BC are Acr preferential binding sites in bladder urothelial cells (Hypothesis 2). We found that DNA damage induces much higher mutations in Inv-BC cells than in N-lnv-BC cells and that N-lnv-BC cells have a much higher DNA damage repair capacity than Inv-BC cells. We also recently found that p63 gene is highly expressed in N-lnv-BC but not in Inv-BC cells, and that introduction of p63 gene elevates DNA repair capacity in Inv-BC cells. These results lead us to hypothesize that H- RAS/FGFR3 mutation-activation enhances DNA repair capacity via activation of p63 and that p53 mutations reduce DNA repair capacity via down regulation of p63 (Hypothesis 3). We will test these hypotheses in cultured human urothelial cells, human bladder tumor tissue samples and transgenic mouse models to understand the relationship between DNA repair capacity and divergent pathways of bladder cancer.
膀胱癌(BC)是美国(US)发现的第五大常见癌症。在美国,烟草烟雾(TS)是BC的主要原因,吸烟者的BC发病率比不吸烟者高5倍。TS含有60多种致癌物;然而,哪些致癌物导致BC尚未得到很好的确定。芳香胺,特别是4-羟基-氨基联苯(ABP)是职业性接触性接触的主要原因,但TS中芳香胺的含量很少。事实上,TS含有的丙烯醛(Acr)是ABP的100,000倍,Acr是一种有效的器官特异性致癌物,能够在大鼠模型中诱导BC。本实验室长期致力于研究化学致癌物诱导的DNA损伤和修复在肿瘤发生中的作用。我们最近取得了三个重要的发现关于Acr:(1)Acr通过形成Acr-DNA加合物,是致突变的DNA损伤;(ii)Acr通过修改和加速自噬介导的降解修饰的DNA修复蛋白抑制DNA修复;和(iii)Acr-DNA加合物在人类细胞中修复不良。我们提出Acr是一种主要的膀胱癌致癌物,其致癌性是通过这三种有害作用(假设1)。大多数BC可分为非侵袭性(N-Inv)和侵袭性(Inv)两类,N-Inv-BC常在H-RAS的密码子12(<20%)和FGFRS基因的密码子248、249、372和652(80%)处发生突变,而Inv-BC主要在p53(30-60%)和RB基因处发生突变。我们假设BC中的这些突变热点是膀胱尿路上皮细胞中的Acr优先结合位点(假设2)。我们发现,DNA损伤诱导Inv-BC细胞比N-lnv-BC细胞高得多的突变,并且N-lnv-BC细胞比Inv-BC细胞具有高得多的DNA损伤修复能力。我们最近还发现,p63基因在N-lnv-BC中高度表达,但在Inv-BC细胞中不表达,并且p63基因的引入提高了Inv-BC细胞中的DNA修复能力。这些结果使我们假设H-RAS/FGFR 3突变激活通过激活p63增强DNA修复能力,并且p53突变通过下调p63降低DNA修复能力(假设3)。我们将在培养的人尿路上皮细胞,人膀胱肿瘤组织样本和转基因小鼠模型中测试这些假设,以了解DNA修复能力和膀胱癌不同途径之间的关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Moon-shong M. TANG其他文献

Eric Moon-shong M. TANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Moon-shong M. TANG', 18)}}的其他基金

Project 2: E-cigarette Smoke Induced Bladder Carcinogenesis and Invasive Cancer Development
项目2:电子烟烟雾诱发膀胱癌发生和侵袭性癌症发展
  • 批准号:
    10661064
  • 财政年份:
    2013
  • 资助金额:
    $ 21.82万
  • 项目类别:
Project 2: E-cigarette Smoke Induced Bladder Carcinogenesis and Invasive Cancer Development
项目2:电子烟烟雾诱发膀胱癌发生和侵袭性癌症发展
  • 批准号:
    10455730
  • 财政年份:
    2013
  • 资助金额:
    $ 21.82万
  • 项目类别:
Core B: Reagent/Service Core
核心 B:试剂/服务核心
  • 批准号:
    10229416
  • 财政年份:
    2013
  • 资助金额:
    $ 21.82万
  • 项目类别:
Core B: Reagent/Service Core
核心 B:试剂/服务核心
  • 批准号:
    10455733
  • 财政年份:
    2013
  • 资助金额:
    $ 21.82万
  • 项目类别:
Project 2: E-cigarette Smoke Induced Bladder Carcinogenesis and Invasive Cancer Development
项目2:电子烟烟雾诱发膀胱癌发生和侵袭性癌症发展
  • 批准号:
    10229413
  • 财政年份:
    2013
  • 资助金额:
    $ 21.82万
  • 项目类别:
Core B: Reagent/Service Core
核心 B:试剂/服务核心
  • 批准号:
    10661071
  • 财政年份:
    2013
  • 资助金额:
    $ 21.82万
  • 项目类别:
Pilot Projects
试点项目
  • 批准号:
    8053425
  • 财政年份:
    2010
  • 资助金额:
    $ 21.82万
  • 项目类别:
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer
脂质过氧化产物诱导 p53 基因 DNA 损伤和肝癌
  • 批准号:
    7905832
  • 财政年份:
    2006
  • 资助金额:
    $ 21.82万
  • 项目类别:
Pilot Projects
试点项目
  • 批准号:
    7320068
  • 财政年份:
    2006
  • 资助金额:
    $ 21.82万
  • 项目类别:
Lipid peroxidation product induced DNA damage in the p53 gene and liver cancer
脂质过氧化产物诱导 p53 基因 DNA 损伤和肝癌
  • 批准号:
    7195526
  • 财政年份:
    2006
  • 资助金额:
    $ 21.82万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 21.82万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了